rethinkPeptides Search
Menu
Study breakdown

The Immune Molecule IL-2 Has a Hidden Opioid Peptide Domain That Relieves Pain

In VitroPreliminary evidence
The takeaway

IL-2 contains a structural domain around its 45th residue that resembles opioid peptides and produces pain relief, revealing molecular overlap between immune signaling and the opioid system.

Hidden opioid domain

The immune molecule IL-2 contains a structural domain resembling endorphin that produces actual pain relief — immune and opioid systems share molecular architecture

What the researchers found

IL-2 contains a structural domain resembling opioid peptides around its 45th Tyr residue that mediates analgesic effects, blocked by anti-opioid antibodies, revealing molecular overlap between immune and opioid signaling.

Why it matters

The discovery that an immune molecule contains an opioid-like pain-relieving domain provides molecular evidence for the long-suspected connection between immune activation and pain modulation.

How the study worked

In-vitro structural analysis of IL-2 identifying opioid-like domains, combined with functional pain assays showing IL-2 analgesia blocked by anti-endorphin, anti-leu-enkephalin, and anti-dynorphin antibodies.

What this study cannot tell us

Structural similarity doesn't guarantee identical function. The physiological relevance of IL-2's analgesic domain at normal immune concentrations is unclear. In-vitro structure-function analysis.

How to read the evidence

Preliminary evidence from structural analysis and functional blocking experiments, providing novel insight into immune-opioid molecular overlap.

When this study was published

Published in 2000. The concept of molecular overlap between immune and opioid systems has been supported by additional structural and functional discoveries.

The bigger picture

Immune activation during infection often changes pain sensitivity. Finding opioid-like domains within immune molecules provides a molecular basis for understanding why illness changes pain perception.

Questions still open

  • Do other cytokines contain opioid-like domains?
  • Is IL-2's analgesic function clinically relevant during immune activation?
  • Could IL-2-derived peptides be developed as pain medications?

Common questions

Can an immune molecule relieve pain?
Yes. IL-2, normally known as an immune signaling molecule, has a built-in domain that structurally resembles natural painkillers. This domain can actually relieve pain through opioid receptor mechanisms.
What does this mean for understanding illness and pain?
It explains at the molecular level why immune activation changes pain sensitivity. When your immune system fights infection and releases IL-2, the opioid-like domain may modulate pain — connecting immunity and pain at the molecular level.

Read the original research

Interleukin-2: structural and biological relatedness to opioid peptides.

Neuroimmunomodulation, 8(1), 20-4

Citation

Jiang, C L; Xu, D; Lu, C L; Wang, Y X; You, Z D; Liu, X Y. (2000). Interleukin-2: structural and biological relatedness to opioid peptides.. Neuroimmunomodulation, 8(1), 20-4.